Immunotherapy for the Treatment of Triple-Negative Breast Cancer.

J Adv Pract Oncol · 2022 · PMC9126339 · PMID 35663156

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

While there was no benefit in overall survival in PD-L1-negative patients, a positive trend was observed for PD-L1-positive patients, with a difference in survival of about 7 months.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.